Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia
S. Pascual Guardia (Barcelona, Spain), J. Marin Corral (Barcelona, Spain), F. Amati (Milan, Italy), S. Aliberti (Milan, Italy), J. Gea (Barcelona, Spain), N. J.Soni (San Antonio, United States of America), A. Rodríguez (Tarragona, Spain), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A Coruña, Spain), M. Kolditz (Dresden, Germany), A. Antonio (San Antonio, United States of America), M. Restrepo (San Antonio, United States of America)
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pascual Guardia (Barcelona, Spain), J. Marin Corral (Barcelona, Spain), F. Amati (Milan, Italy), S. Aliberti (Milan, Italy), J. Gea (Barcelona, Spain), N. J.Soni (San Antonio, United States of America), A. Rodríguez (Tarragona, Spain), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A Coruña, Spain), M. Kolditz (Dresden, Germany), A. Antonio (San Antonio, United States of America), M. Restrepo (San Antonio, United States of America). Novel Pseudomonas aeruginosa scoring system to guide empiric anti-pseudomonal therapy in COPD patients with community-acquired pneumònia. 1788
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: